approved glp-1 agonists GLP-1: Genetic Variants Related to RA Medications GLP-1 receptor agonists and next-generation
Description
Bimagrumab Bimagrumab is a human monoclonal antibody that stimulates skeletal muscle growth by blocking the activin type II receptor (ActRII) and it is administered as a four-weekly intravenous infusion [96]
Science Quickly is produced by me, Kendra Pierre-Louis, along with Fonda Mwangi, Sushmita Pathak and Jeff DelViscio
Madsbad S
The most common side effects for GLP-1 RAs were nausea, vomiting, diarrhea and constipation
